Renowned Gastroenterologist, Dr. Adam S. Cheifetz, Joins AegirBio’s Scientific Advisory Board
AegirBio AB announces the appointment of Dr. Adam S. Cheifetz to its Scientific Advisory Board.Dr. Cheifetz, Director of the Center for Inflammatory Bowel Disease at Beth Israel Deaconess Medical Center and Professor of Medicine at Harvard Medical School, brings unparalleled expertise in the field of gastroenterology, particularly in the treatment of Crohn’s disease, ulcerative colitis, and other inflammatory bowel diseases. "We are honoured to welcome Dr. Cheifetz to our Scientific Advisory Board. His extensive knowledge, ground-breaking research, and leadership in the field of